Affinium Pharmaceuticals
Latest round
- Series A
Last raised
- Mar 2007
Total raised
- $18M
Investors
- 4
About Affinium Pharmaceuticals
Affinium Pharmaceuticals focuses on developing advanced therapeutic solutions aimed at addressing significant health challenges.Affinium Pharmaceuticals, founded in 2000 and headquartered in Austin, US, specializes in pharmaceutical advancements. The company underwent a strategic pivot in its operations when, in February 2014, it was acquired by Debiopharm Group, which involved the transfer of its assets and platform. The company has successfully completed 4 deals to date, with the most recent deal occurring in February 2014.Affinium Pharmaceuticals specializes in providing innovative therapeutic solutions designed to address specific challenges within the healthcare market. Their core offerings include advanced pharmaceutical products that enhance treatment efficacy and improve patient outcomes. These products facilitate seamless integration into existing treatment protocols, thereby optimizing healthcare delivery for various patient demographics. Key clients range from healthcare providers to large pharmaceutical companies, indicating a diverse customer base that spans geographical markets including North America, Europe, and Asia.Affinium Pharmaceuticals operates a revenue model structured around a combination of product sales and strategic partnerships, allowing for flexibility in catering to its diverse clientele. Clients engage with the company's offerings through tailored agreements, which may include product supply contracts or collaborative research ventures. Each transaction typically involves detailed negotiations to determine the most suitable pricing plans for both parties, ensuring that the terms align with customer expectations and market standards.Affinium Pharmaceuticals plans to enhance its product portfolio with new therapeutic solutions scheduled for launch in the upcoming years. The company is also targeting expansion into new geographic markets, specifically aiming to establish a presence in Asia by 2025.00 mn will be utilized to support these initiatives, including investment in research and development to bring these new products to market.
Who invested in Affinium Pharmaceuticals
4 investors across 1 round
See all investors in Affinium Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 26, 2007
Amount
$18M
Investors
Questions about Affinium Pharmaceuticals
Who invested in Affinium Pharmaceuticals?
Affinium Pharmaceuticals has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Affinium Pharmaceuticals raised?
Affinium Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Affinium Pharmaceuticals last raise money?
Affinium Pharmaceuticals's most recent round on record is a Series A, in Mar 2007.
What does Affinium Pharmaceuticals do?
Affinium Pharmaceuticals focuses on developing advanced therapeutic solutions aimed at addressing significant health challenges.
Where is Affinium Pharmaceuticals headquartered?
Affinium Pharmaceuticals is headquartered in Austin, US.
Which VCs invest in companies like Affinium Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Affinium Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Affinium Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.